Multiple Myeloma CancerMyeloma is a type of cancer that begins in cells located in the bone marrow called plasma cells. Bone marrow is the spongy tissue inside many of our large bones. Bone marrow produces several different types of blood cells. Because myeloma can occur in several different places in the body, it is frequently called multiple myelomas.

The most common form of plasma cell cancer, myeloma can develop wherever the plasma cells are located. It can be found anywhere there is bone marrow, including the pelvis, spine, and ribcage.

The buildup of myeloma cells results in:

  • Fewer healthy, normal blood cells in the bone marrow
  • Weakened or damaged bones
  • Two kinds of bone cells work together to develop a bone into its proper shape:
  • Osteoblasts make bone
  • Osteoclasts dissolve bone

Myeloma cells produce a substance which stimulates osteoclasts and results in a faster destruction of bone. Complications include infection, bone pain and fractures.

Types of myelomas:

  • Smoldering or indolent multiple myelomas
  • Active multiple myelomas
  • Solitary plasmacytoma of the bone
  • Multiple solitary plasmacytomas
  • Extramedullary plasmacytoma
  • Light chain myeloma
  • Non-secretory myeloma
  • Immunoglobulin D (IgD) myeloma (rare)
  • Immunoglobulin E (IgE) myeloma (rare)

Multiple Myeloma Causes & SymptomsCauses, Risk Factors & Symptoms of Multiple Myeloma

It's not clear what causes most multiple myeloma. Scientists have found few risk factors that could affect a person’s chance of developing multiple myelomas.

Risk factors for multiple myeloma includes:

  • History of monoclonal gammopathy of undetermined significance
  • Age — risk for developing myeloma goes up with age. Most people diagnosed are 65 years of age or older.
  • Gender — men are slightly more likely to develop myeloma than women.
  • Race — myeloma is more than twice as common in African Americans than white Americans. The reason for this is not known.
  • Radiation
  • Workplace exposures
  • Having other plasma cell diseases
  • Family history of multiple myelomas
  • Being overweight or obese
  • Farming

Signs and symptoms of multiple myeloma includes:

  • Bone pain and bone damage and fractures
  • Symptoms caused by too much calcium in the blood
  • Swollen ankles
  • More prone to infection
  • Pneumonia
  • Weight loss
  • Anemia
  • Nervous system problems — numbness, sudden/severe pain, tingling, muscle weakness, confusion, dizziness, carpal tunnel
  • Breathlessness
  • Increased thickening/stickiness of the blood — headaches, dizziness, weakness, drowsiness, fatigue, oozing cuts, blurred vision, bruising
  • Pale skin tone
  • High blood protein levels
  • Low white blood cell counts

Who Gets Multiple Myeloma CancerWho Gets Multiple Myeloma

Most individuals diagnosed with multiple myelomas are men. The risk of developing multiple myeloma increases with age and those of African ancestry have a higher risk of developing myeloma. The reasons for this increased risk are not known.

Approximately 0.7 percent of men and women will be diagnosed with myeloma at some point during their lifetime, based on 2010-2012 data.

Multiple Myeloma Cancer PrognosisPrognosis if You Have Multiple Myeloma

According to the National Cancer Institute’s SEER database:

For all cases of multiple myelomas combined (in both adults and children), the 5-year relative survival is about 48.5 percent.

The number of new cases of myeloma was 6.5 per 100,000 men and women per year. The number of deaths was 3.3 per 100,000 men and women per year. These rates are age-adjusted and based on 2009-2013 cases and deaths.

Approximately 0.7 percent of men and women will be diagnosed with myeloma at some point during their lifetime, based on 2010-2012 data.

In 2013, there were an estimated 95,688 people living with myeloma in the United States.

The 5-year relative survival rate for multiple myelomas:

  • Stage I and II (localized) – 69.6 percent
  • Stage III and IV (distant) – 47.4 percent

Multiple Myeloma Cancer ProtocolsProtocols: How to Treat Multiple Myeloma

By far the best alternative cancer treatment for multiple myelomas is a mineral-based treatment, with added minerals specific to bone cancer.

As long as a cancer patient does not have a type of cancer that is more dangerous than their bone cancer (e.g. lung cancer), it is best to design the cancer protocol to focus on the bone cancer.

Cellect not only includes cesium chloride but also has minerals in the formula.

For bone cancer, a High RF Frequency Protocol — Plasma is required, as it can get to any cancer cell in the body, even when the bloodstream does not get to the cancer cells. It is commonly used with the Cellect-Budwig.

• Primary: Cellect-Budwig Protocol with High RF Frequency Generator
• Also recommended: Fucoidan
• Optional: Omega-3, Cellect, Calcium, Essiac Tea, Noni Juice, Raw Food, CoQ10, AHCC, IP6, Clodronate

Depending on the stage of cancer and other factors, conventional treatment options include:

  • Surgery
  • Radiation
  • Chemotherapy
  • Stem cell transplant
  • Targeted therapy
  • Palliative therapy

How to Prevent Multiple Myeloma CancerHow to Prevent Multiple Myeloma

Screening tests are important ways to find cancer if you are at risk but do not have symptoms. Unfortunately, no standardized screening tests have been shown to improve multiple myeloma outcomes.

Changes in lifestyle can help prevent many types of cancer. However, no known lifestyle changes can prevent myelomas.

Immune System HealthImmune System Health

A healthy immune system remains your body's best defense. Not only is a weak immune system a major reason patients have cancer — and cancer itself can further weaken the immune system.

Beta glucans help regulate the immune system, making it more efficient. In addition, beta glucans stimulate white blood cells (lymphocytes) that bind to tumors or viruses and release chemicals to destroy it.

Beta Glucan has been approved in Japan, Australia, South Korea, and Taiwan as an immunoadjuvant therapy for cancer. In fact, helping with cancer is just the beginning with Beta Glucan. There have thousands of studies showing the product can protect against infections, lower your cholesterol, lower blood sugar, reduce stress, increase your antibody production, heal wounds, help radiation burns, overcome mercury-induced immunosuppression (like Thimerosal, used as a preservative in vaccines), help with diabetes, and even naturally prevent metastasis (or the spreading of your cancer).

Harvard Medical School suggests following general good-health guidelines is the single best step you can take toward keeping your immune system strong and healthy:

  • Don't smoke.
  • Eat a diet high in fruits, vegetables, and whole grains, and low in saturated fat.
  • Exercise regularly.
  • Maintain a healthy weight.
  • Control your blood pressure.
  • If you drink alcohol, drink only in moderation.
  • Get adequate sleep.
  • Take steps to avoid infection, such as washing your hands frequently and cooking meats thoroughly.
  • Get regular medical screening tests for people in your age group and risk category.

More Information: Building the Immune System

Healthy DietHealthy Diet

Your diet plays a role in a healthy immune system. The top vitamins your immune system needs to perform include:

  • Vitamin C — helps to repair and regenerate tissues and aids in the absorption of iron
  • Vitamin E — a powerful antioxidant that helps your body fight off infection
  • Vitamin B6 — supports adrenal function and is necessary for key metabolic processes
  • Vitamin A — aids immune function and helps provide a barrier against infections
  • Vitamin D — modulates cell growth, promotes neuromuscular and immune function, and reduces inflammation
  • Folate — key in development of red blood cells (a lack of Folate can make the body susceptible to cancer)
  • Iron — helps your body carry oxygen to cells
  • Selenium — slows the body's overactive responses to certain aggressive forms of cancer
  • Zinc — slows the immune response and control inflammation in your body

Sources: American Cancer Society, National Cancer Institute, Cancer Research UK

Save

Save

Save

Save

Save